The rise of CGT-focused CDMOs reflects the growing demand for specialized biomanufacturing solutions. By offering GMP-compliant environments, technical expertise, and end-to-end development support, these partners enable biotech companies to scale advanced therapies efficiently while maintaining quality, safety, regulatory alignment, and consistent manufacturing outcomes across clinic... https://xelleratherapeutic.wixsite.com/xellera-therapeutics/post/why-cgt-focused-cdmos-are-the-future-of-biomanufacturing